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ABSTRACT 
BACKGROUND Fugitive diagnosis “escape from true diagnosis” of neurological disorders is very common in elderly 
patients. It’s not always an underlying disease symptom or progression in old age. Aim of this study is to determine the 
frequency and nature of fugitive diagnosis of neurodegenerative brain disorders in old age.
MATERIAL AND METHODS 
STUDY DESIGN A study was conducted in private Neuro-clinic in Lahore. Study duration is 3 years from to 1st January, 
2017 to 31th December, 2019. It was a prospective, cross sectional study. Inclusion criteria: 1) Age >60years 2) 
Neurodegenerative brain disorders including vascular dementia 3) with or without associated co morbidities e.g., DM, 
HTN, IHD. Exclusion criteria: age <60, all acquired other neurological disorder
RESULTS 
Total number of patients (n=2570) visited to Neuro-clinic with various neurological disorders.950 patients had 
neurodegenerative diseases. A total of 241 patients(n=241) with neurodegenerative diseases like Parkinson’s 
disease, Alzheimer’s disease, Lewy body disease vascular dementia and fronto-temporal dementia having fugitive 
diagnosis during their course of treatment were included in the study. Study sample consisted of 134 males and 107 
female patients. The patients included in study were aged equal to or more than 60 years. True diagnosis was as 
follows; refusal to take oral medications or keeping food in mouth 73/241, (30.29%), misdiagnosed as advanced 
dementia or early Alzheimer’s disease, Serotonin Syndrome 23/241, (09.54%), Subacute Encephalopathy 67/241, 
(27.80%) caused by infections e.g. urinary tract infection or pneumonia, hyponatremia, were taken as advanced 
widespread disease or deepening encephalopathy due to metabolic cause,  Depression in 47/241, (19.50%), was 
taken as worsening of symptoms or  polypharmacy. Impulse control disorders 31/241, (12.86%) were misdiagnosed 
as extremes of behavior with efforts leading to hospitalization in psychiatric institution.
CONCLUSION 
Fugitive diagnosis in patients with neurologic symptoms and signs, especially in neurodegenerative disorders results in 
worsening of patient condition with no chance of benefit. The patient is subjected to inappropriate, ineffective and 
potentially harmful treatment. Fugitive diagnosis fails to address symptoms, delays appropriate therapy, and may lead 
to worst prognosis. Finally, it may lead to unnecessary higher cost of treatment for patient in particular and health care 
system in general. So clinical guidelines should be made to overcome these situations.
KEYWORDS: Fugitive diagnosis, Neurodegenerative brain disorders, Old age, Depression, Impulse control disorder 
(ICD), Serotonin syndrome 
INTRODUCTION 
Neurodegenerative diseases are not the normal part of 
ageing. Alzheimer’s disease, Parkinson’s disease, 
vascular dementia and frontotemporal dementia are 
the main neurodegenerative diseases affecting elderly 
population. Alzheimer’s disease is characterized by 
progressive impairment in cognition including memory, 
language, visuospatial orientation and executive 
functions. (1) Diagnosis of Alzheimer’s disease mostly 
relies on history and physical examination. Diagnostic 
evaluation of suspected Alzheimer patient includes 
thyroid function tests, vitamin B12 levels, and serology 
for syphilis, HIV, Lyme  and neuroimaging to rule out the 
structural causes. (2)
 Parkinson’s disease involves motor and non-motor 
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manifestations. Motor features include rigidity, 
bradykinesia, tremor and postural instability late in 
disease (3).  Dopaminergic drugs, monoamine oxidase 
inhibitors (MAOI), catecholamine -o- methyl transferase 
(COMT) are treatment options available currently (4). 
Cerebrovascular disease is the leading cause of 
dementia in elderly. (5) Vascular dementia results from 
multiple cortical infarctions in strategic areas of the 
brain (5). Vascular dementia has a stepwise and slower 
progression and is potentially preventable if risk factors 
are adequately treated and recognized in time. 
Fronto-temporal dementia (FTD) is a non-Alzheimer’s 
dementia and encompasses diverse clinical 
presentation such as behavior, language and 
movement disorders, occurs between the ages of 
45-65 years. (6)
Elderly patients may present with overlapping features 
of multiple disorders. Therefore, elderly patients require 
multidisciplinary approach to distinguish age related 
changes versus underlying disease, superimposed 
infections, polypharmacy, psychiatric disturbance and 
delirium. 
Depression is more prevalent in younger than in older 
population and manifests differently. Depression in 
older population uncompressed more cognitive 
symptoms than affective symptoms. Thus have 
devastating consequences. (7) Therefore may leads to 
unnecessary diagnostic evaluation for underlying 
malignancy and sepsis.
It is very common to hear from caregivers or from loved 
ones about challenges of administrating medication to 
patients with Alzheimer’s or other dementias. (8) This 
resisted behavior should be promptly investigated and 
dealt with. Ask about the discomfort caused by 
medications or their side effects that are not 
communicated to patient and care giver because of 
patient fear such as pills are bitter or hard to swallow. 
(9). Management of such problems should be taught and 
told to caregivers and attendants of the patient, 
proactive solution is sought.  Never force the patient, 
keep calm and try after sometime again, stick to the 
routine, if side effects are reported, talk to the 
physician. (10)
Impulse control disorders (ICD) are defined as 
compulsive, pleasurable behaviors performed 
repetitively and excessively (11). Typical symptoms 
include pathological gambling, hypersexuality, binge 
eating, compulsive shopping and behavioral disorders 
(Punding, hobbyism) (12). Incidence of impulse control 
disorders (ICDs) in Parkinson’s disease is 13%. (13) 
Dopaminergic agonists are associated with 2-to 
3.5-fold increase risk of ICDs in patients with 
Parkinson’s disease (14.)
Patients who are on antidepressants, or antipsychotics 
should be assessed frequently for signs of serotonin 
syndrome prior to labelling progression or part of 
underlying disease. Alternative diagnosis or reversible 
conditions other than underlying disease progression 
and worsening should be sought judiciously (15)
This study was conducted to determine the frequency 
and nature of fugitive diagnosis of Neuro-Degenerative 
brain disorders in old age.
MATERIAL AND METHODS 
A Cross Sectional, Prospective study was conducted in 
a private Neuro- clinic in Lahore from 1st January 2017 
to 31th December 2019. Inclusion criteria: 1) Age 
>60yrs 2) Neurodegenerative brain disorders including 
vascular dementia 3) with or without 
associated co morbidities e.g. DM, HTN, IHD. Exclusion 
criteria: age <60, all acquired other neurological 
disorders. 
STATISTICAL ANALYSIS
Statistical analysis was done using SPSS version-23. 
Data for age, gender, true diagnosis for 
neurodegenerative diseases, causes of encephalopathy 
were described by using frequency and percentages. 
Mean and standard deviation were calculated for 
quantitative variables.
RESULTS 
Total number of patients (n=2570) visited to 
Neuro-clinic with various neurological disorders.950 
patients had neurodegenerative diseases. A total of 
241 patients(n=241) with neurodegenerative diseases
like Parkinson’s disease, Alzheimer’s disease, vascular 
dementia and frontotemporal dementia having fugitive 
diagnosis during their course of treatment were 
included in the study. Study sample consisted of 134 
males and 107 female patients.
The patients included in study were aged equal to or 
more than 60 years. patients’ symptoms were 
considered as part of disease progression but true 
diagnosis was as follows; refusal to take oral 
medications or keeping food in mouth 73/241, 
(30.29%), was due to poor oral cavity hygiene and 
denture problems which was misdiagnosed as 
advanced dementia or early Alzheimer’s disease. 
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Subacute Encephalopathy 67/241, (27.80%) caused 
by infections e.g., urinary tract infection or pneumonia, 
hyponatremia as these metabolic causes are reversible 
conditions, not a part of progression of disease, were 
taken as advanced widespread disease or deepening 
encephalopathy due to metabolic cause. Depression 
was reported in 47/241, (19.50%), is an associated 
but treatable condition, was taken as worsening of 
symptoms or can be a part of polypharmacy. Impulse 
control disorders 31/241, (12.86%) as part of drug 
side effect, can be lessen with reducing the dose or 
using alternative medication, were misdiagnosed as 
extremes of behavior with efforts leading to 
hospitalization in psychiatric institution.
Patients with Alzheimer’s disease (19 /241), 
Parkinson’s disease (57 /241), Frontotemporal 
dementia (4/241), vascular disease (94 /241) delirium 
(67 /241). 
Comorbidities Diabetes mellitus (43/241), Hypertensive 
(33/241), Ischemic heart disease (38/241) 
Patients resisting medications or refusal to cope up 
with personal and oral hygiene are the most frequent 
and serious complaints in clinic from caregiver or 
relatives that we must investigate. In our study highest 
number of patients 73/241, (30.29%) were reported 
with refusal to take oral medication or keeping food in 
mouth, 41 males, 32 females, were misdiagnosed as 
advanced dementia or early Alzheimer’s disease. Table 
given below.
Table 1 –age distribution for patient (refusal to intake)
Serotonin syndrome is a commonly encountered as 
side effect of antidepressants and atypical 
antipsychotics in patients who are being treated for 
psychotic depression (15).  Major features of serotonin 
syndrome include wide variety of symptoms mental 
status changes such as delirium, restlessness, 
irritability and anxiety, autonomic manifestations such 
as diaphoresis, tachycardia, hypertension, 
hyperthermia and vomiting and diarrhea (16).  Among 
elderly mortality is reported to be 11% (17).  Serotonin 
syndrome frequency reported in our study is 23/241, 
(09.54%), 12 males and 11 females.
Table 2 – Age Distribution (serotonin syndrome)
Subacute encephalopathy 67/241, (27.80%) was 
caused by infections e.g. urinary tract infection or 
pneumonia, electrolyte abnormalities as 
hyponatremia.It was misdiagnosed as advanced 
widespread disease or deepening encephalopathy due 
to underlying disease progression.
Table 3 - age distribution (sub-acute encephalopathy)
Table 5-Causes of sub-acute encephalopathy
Depression is not a normal part of aging. Elderly have 
less obvious symptoms of depression, such as feeling 
tired, trouble sleeping and irritability, but they do not 
present with sadness (18). Depression in our study 
reported to be among 47/241, (19.50%), (33 males, 
14 females) was taken as worsening of symptoms or 
polypharmacy.
Table -3 age distribution for depression 
Though evidence of ICDs is fairly common, yet are 
under-reported by patients and not frequently 
recognized by clinicians. ICDs carry significant morbidity 
and mortality, and
are treatable by combination of pharmacotherapy and 
behavioral therapy. (19). Impulse control disorders 
31/241, (12.86%), (18 males, 13 females), were 
misdiagnosed as extremes of behavior leading to 
hospitalization and were attributed to dopaminergic 
drugs. 
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DISCUSSION 
Challenges often arise during evaluation of an elderly 
patient and are due to multiple comorbidities, 
polypharmacy and ageing. 
Delirium is the greatest geriatric symptom in the 
emergency department and frequently misdiagnosed. 
(20) It has varied presentations in elderly. Most difficult 
patients are those who have underlying 
neurodegenerative disease-causing dementia or 
behavioral features. Most delirious cases are 
mishandled and mistreated. Delirium is confused with 
underlying disease progression, worsening or cause is 
pinned on ageing process without giving an effective 
thought to infections, side effects of drugs, 
polypharmacy and depression. 
Antidepressants and antipsychotics are usually 
administered to control the behavioral symptoms 
associated with dementia among elderly. Interactions 
of drugs should be checked prior to administering 
medications because polypharmacy and medication 
interaction puts them at higher risk of serotonin 
syndrome. Treatment of serotonin syndrome is to 
discontinue causative agent, provide supportive care, 
and with benzodiazepines. Benzodiazepines should be 
given in lower doses and with caution in older people. 
(21) Think about possible cause of serotonin syndrome if 
older patient presents with altered mental status, 
inquire about the recent changes in medications or 
addition of new medications.
Symptoms of depression in older adults can mistakenly 
be attributed to other illnesses, medications and 
ageing. (22) Older adults are at risk of misdiagnosis and 
lack of treatment because their symptoms can mimic 
normal age- related issues. (22) According to American 
Academy of Geriatrics Psychiatry most common 
symptoms related to depression in elderly includes; 
persistent sadness, feeling tired or slowed down, 
excessive worries about health problems, anxiety, sleep 
problems, feeling helpless. (23) There is always a risk of 
suicide with major depressive disorder, therefore by 
early treatment and recognition. This dreadful 
consequence can be avoided. 
Our study main aim was to determine how many 
patients who have multiple comorbidities and 
underlying neurodegenerative disorder are treated 
when presented with delirium. It was found that most 
patients refused to take medications because of some 
reason that was not recognized by their caregiver or 
doctor. Diagnosis is difficult in elderly patients with 
multiple comorbidities; therefore, an algorithm should 
be made to counterpoise the issue. 
CONCLUSION
Fugitive diagnosis in patients with neurologic symptoms 
and signs, especially in neurodegenerative disorders 
results in worsening of patient condition with no chance 
of benefit. The patient is subjected to inappropriate, 
ineffective and potentially harmful treatment. Fugitive 
diagnosis fails to address symptoms, delays 
appropriate therapy, and may lead to worst prognosis. 
Finally, it may lead to unnecessary higher cost of 
treatment for patient in particular and health care 
system in general. So clinical guidelines should be 
made to overcome these situations.
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PREVALENCE OF DEPRESSION IN PATIENTS WITH 
MIGRAINE, A CROSS-SECTIONAL STUDY FROM A 
TERTIARY CARE HOSPITAL
Zuhaib Ahmed1, Umar Farooque2, Aijaz Ali3, Syeda Urooj Riaz4, Farah Yasmin5, Muhammad Ramzan6, Vijaya Chaitanya Bollampally7, 
Ehtesham Zahoor8, Omer Cheema9, Mujeeb Ur Rehman10, Rizwan Farooque11, Muhammad Daim Bin Zafar12
BACKGROUND
Headache is one of the most common presenting complaints in patients attending primary care centers and the 
majority of them have primary headache syndromes. Depressive disorders are among the leading causes of disability 
globally and can further complicate the clinical manifestation if coupled with other comorbidities. Therefore, the 
primary objective of our study was to determine the prevalence of depression in migraine patients presenting at a 
tertiary care hospital to better understand the leading causes of the disease.
METHODS
A cross-sectional study was carried out between December 2019 and June 2020 (six months) including 66 migraine 
patients between 18 and 45 years of age presenting to the neurology outpatient clinics at a tertiary care hospital in 
Karachi, Pakistan. Non-probability convenience-based sampling technique was used to calculate the sample size, and 
the data was collected via face-to-face interviews. The first section of the questionnaire consisted of 
socio-demographic factors such as age, gender, educational, occupational, and marital status in addition to the clinical 
characteristics such as the duration of the disease and the frequency of migraine attacks. The second section 
assessed the depressive symptoms of the participants using the Patient Health Questionnaire-9 (PHQ-9) and any 
patient with a score of five or more was considered as suffering from a depressive disorder. All statistical analysis was 
conducted using Statistical Package for Social Sciences (SPSS) version 23.0.
RESULTS
Out of a total of 66 participants, almost two-third (n=43, 65.2%) were males, while nearly one-third (n=23, 34.9%) 
were females. The average age of the patients was 27.59±5.37 years. The frequency of depression was observed in 
approximately three-quarters (n=49, 74.2%) of the migraine patients in our study. The prevalence of depression was 
only significantly associated with disease duration (p=0.027) and the number of migraine attacks (p=0.015).
CONCLUSION
In conclusion, the prevalence of depression was found to be significantly high among migraine patients, therefore 
migraine might be related to depression. Depression should not be ignored while evaluating migraine subjects for good 
prognosis and management of the disease.
KEYWORDS migraine, psychiatric disorders, depression
INTRODUCTION
Migraine is a chronic neurological disorder that is 
characterized by pulsating headache (i.e. feeling of 
fullness over the forehead) that occurs in recurrent 
attacks and is often unilateral [1]. It can be 
accompanied by other clinical manifestations including 
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